BioSpace News Archive

Genetown

Inozyme Pharma to Participate in Upcoming Investor Conferences

Inozyme Pharma, Inc. today announced that Axel Bolte, MSc, MBA, the company’s co-founder, president, and chief executive officer, will participate in the following investor conferences.

November 7, 2022
·
1 min read
Genetown

Laborie’s Optilume® Issued Category 1 CPT Code by American Medical Association

Laborie Medical Technologies Corp, a specialist medical technology company, announced that the American Medical Association has issued the new Category 1 Current Procedural Terminology code 5X000 to report cystourethroscopy with mechanical urethral dilation and therapeutic drug delivery via coated balloon.

November 7, 2022
·
2 min read
ORYZON Announces Oral Data Presentation at the Upcoming 64th American Society of Hematology Annual Conference

Oryzon Genomics, S.A has been selected for oral presentation at the upcoming 64th American Society of Hematology (ASH) Annual Meeting and Exposition, to be held December 10-13, 2022 in New Orleans.

November 7, 2022
·
6 min read
Biotech Beach

Alignment Healthcare to Participate in the 2022 Stephens Annual Investment Conference and Piper Sandler 34th Annual Healthcare Conference

Alignment Healthcare, Inc. today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will participate in the following conferences.

November 7, 2022
·
1 min read
Pharm Country

Genenta Update at SITC22 Indicates Potential for Anti-Tumor Immune System Reset after Temferon™ Treatment in Glioblastoma Patients

Genenta Science will present at the 2022 annual meeting of the Society for Immunotherapy of Cancer (SITC) data showing signs of Temferon-induced changes in the tumor microenvironment of patients affected by glioblastoma multiforme and activation of the immune system that may result in the inhibition of tumor growth.

November 7, 2022
·
3 min read
Genetown

EyePoint Pharmaceuticals Announces Participation at Upcoming November 2022 Investor Conferences

EyePoint Pharmaceuticals, Inc. announced that EyePoint Pharmaceuticals will present at the following upcoming conferences.

November 7, 2022
·
1 min read
Pharm Country

Lisata Therapeutics Announces Participation in Upcoming Conferences in November 2022

Lisata Therapeutics, Inc. today announced that management will participate in the following events.

November 7, 2022
·
2 min read
Business

CinCor Pharma Appoints Michael W. Kalb, Executive Vice President and Chief Financial Officer

CinCor Pharma, Inc. announced the appointment of Michael W. Kalb as Executive Vice President and Chief Financial Officer, effective November 4.

November 7, 2022
·
7 min read
Drug Development

TCR² Therapeutics Presents Preclinical Data on Functional Activity of Gavo-cel at the Society for Immunotherapy of Cancer

TCR2 Therapeutics Inc. announced the poster presentation of new preclinical data at the Society for Immunotherapy of Cancer Conference 37th Annual Meeting, taking place November 8-12, 2022.

November 7, 2022
·
5 min read
Drug Development

Bridge Biotherapeutics Initiates Phase 2 Clinical Trial of BBT-877 in Patients with Idiopathic Pulmonary Fibrosis

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis and inflammation, announced the initiation of a Phase 2a clinical trial evaluating the efficacy, safety, and tolerability of BBT-877 in patients with idiopathic pulmonary fibrosis (IPF).

November 7, 2022
·
3 min read